Esther Picillo

1.3k total citations
32 papers, 817 citations indexed

About

Esther Picillo is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Esther Picillo has authored 32 papers receiving a total of 817 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 10 papers in Cardiology and Cardiovascular Medicine and 7 papers in Genetics. Recurrent topics in Esther Picillo's work include Muscle Physiology and Disorders (12 papers), Neurogenetic and Muscular Disorders Research (7 papers) and Cardiomyopathy and Myosin Studies (7 papers). Esther Picillo is often cited by papers focused on Muscle Physiology and Disorders (12 papers), Neurogenetic and Muscular Disorders Research (7 papers) and Cardiomyopathy and Myosin Studies (7 papers). Esther Picillo collaborates with scholars based in Italy, Poland and France. Esther Picillo's co-authors include Luisa Politano, Emanuela Viggiano, Laura Manna, Angelo Elio Gravino, Fabrizio Vitale, Stefano Reale, Luigia Passamano, Manuela Ergoli, Antonella Taglia and Paola D′Ambrosio and has published in prestigious journals such as Nature Communications, International Journal of Molecular Sciences and Annals of the New York Academy of Sciences.

In The Last Decade

Esther Picillo

30 papers receiving 792 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Esther Picillo Italy 17 458 244 164 162 117 32 817
Peter P. Nghiem United States 16 475 1.0× 29 0.1× 38 0.2× 73 0.5× 54 0.5× 28 784
Carine Machado Azevedo Brazil 12 118 0.3× 126 0.5× 121 0.7× 37 0.2× 104 0.9× 23 514
S. K. Shankar India 19 149 0.3× 140 0.6× 144 0.9× 38 0.2× 100 0.9× 40 797
Xiaohong Wang China 15 241 0.5× 115 0.5× 38 0.2× 54 0.3× 23 0.2× 45 832
John Dutton United States 16 133 0.3× 269 1.1× 84 0.5× 83 0.5× 33 0.3× 28 791
A.L. Taratuto Argentina 12 282 0.6× 42 0.2× 79 0.5× 28 0.2× 62 0.5× 35 552
Claire Cooke‐Yarborough Australia 14 133 0.3× 54 0.2× 90 0.5× 37 0.2× 14 0.1× 23 608
Hoda Abdel‐Hamid United States 12 293 0.6× 17 0.1× 22 0.1× 50 0.3× 129 1.1× 31 523
Natalie Walker United States 15 281 0.6× 28 0.1× 88 0.5× 31 0.2× 87 0.7× 36 830
Kelly Howell United States 12 304 0.7× 22 0.1× 45 0.3× 156 1.0× 125 1.1× 16 633

Countries citing papers authored by Esther Picillo

Since Specialization
Citations

This map shows the geographic impact of Esther Picillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther Picillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther Picillo more than expected).

Fields of papers citing papers by Esther Picillo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esther Picillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther Picillo. The network helps show where Esther Picillo may publish in the future.

Co-authorship network of co-authors of Esther Picillo

This figure shows the co-authorship network connecting the top 25 collaborators of Esther Picillo. A scholar is included among the top collaborators of Esther Picillo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esther Picillo. Esther Picillo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Traverso, Monica, Michele Iacomino, Marco Di Duca, et al.. (2024). DAG1 haploinsufficiency is associated with sporadic and familial isolated or pauci-symptomatic hyperCKemia. European Journal of Human Genetics. 32(3). 342–349. 1 indexed citations
4.
Torella, Annalaura, Francesca Del Vecchio Blanco, Esther Picillo, et al.. (2023). Alu-Mediated Insertions in the DMD Gene: A Difficult Puzzle to Interpret Clinically. International Journal of Molecular Sciences. 24(11). 9241–9241. 2 indexed citations
5.
Viggiano, Emanuela, Esther Picillo, Luigia Passamano, et al.. (2023). Spectrum of Genetic Variants in the Dystrophin Gene: A Single Centre Retrospective Analysis of 750 Duchenne and Becker Patients from Southern Italy. Genes. 14(1). 214–214. 9 indexed citations
6.
Savarese, Marco, et al.. (2022). Bi-Allelic DES Gene Variants Causing Autosomal Recessive Myofibrillar Myopathies Affecting Both Skeletal Muscles and Cardiac Function. International Journal of Molecular Sciences. 23(24). 15906–15906. 6 indexed citations
7.
Picillo, Esther, Annalaura Torella, Luigia Passamano, Vincenzo Nigro, & Luisa Politano. (2022). Autosomal dominant Ullrich congenital muscular dystrophy due to a de novo mutation in COL6A3 gene. A case report. PubMed Central. 1 indexed citations
8.
Petillo, Roberta, Paola D′Ambrosio, Manuela Ergoli, et al.. (2020). CLCN1 Molecular Characterization in 19 South-Italian Patients With Dominant and Recessive Type of Myotonia Congenita. Frontiers in Neurology. 11. 63–63. 5 indexed citations
9.
Spitali, Pietro, Kristina Hettne, Roula Tsonaka, et al.. (2018). Cross‐sectional serum metabolomic study of multiple forms of muscular dystrophy. Journal of Cellular and Molecular Medicine. 22(4). 2442–2448. 27 indexed citations
10.
Viggiano, Emanuela, et al.. (2017). Skewed X‐chromosome inactivation plays a crucial role in the onset of symptoms in carriers of Becker muscular dystrophy. The Journal of Gene Medicine. 19(4). 18 indexed citations
11.
Viggiano, Emanuela, Manuela Ergoli, Esther Picillo, & Luisa Politano. (2016). Determining the role of skewed X-chromosome inactivation in developing muscle symptoms in carriers of Duchenne muscular dystrophy. Human Genetics. 135(7). 685–698. 48 indexed citations
12.
Martone, Julie, Francesca Briganti, Ivano Legnini, et al.. (2016). The lack of the Celf2a splicing factor converts a Duchenne genotype into a Becker phenotype. Nature Communications. 7(1). 10488–10488. 16 indexed citations
13.
Petillo, Roberta, Paola D′Ambrosio, Annalaura Torella, et al.. (2015). Novel mutations in LMNA A/C gene and associated phenotypes.. PubMed Central. 34(2-3). 116–9. 18 indexed citations
14.
Manente, Lucrezia, et al.. (2015). Molecular evidence of apoptotic pathway activation in semen samples with high DNA fragmentation.. PubMed. 29(2). 289–94. 16 indexed citations
15.
Palladino, Alberto, Luigia Passamano, Antonella Taglia, et al.. (2011). Cardiac involvement in patients with spinal muscular atrophies.. PubMed. 30(3). 175–8. 22 indexed citations
16.
Borja-Cabrera, Gulnara Patrı́cia, et al.. (2009). Nucleoside hydrolase DNA vaccine against canine visceral leishmaniasis. PubMed. 1(1). 104–109. 20 indexed citations
17.
Manna, Laura, Angelo Elio Gravino, Esther Picillo, Nicola Decaro, & Canio Buonavoglia. (2008). Leishmania DNA Quantification by Real‐time PCR in Naturally Infected Dogs Treated with Miltefosine. Annals of the New York Academy of Sciences. 1149(1). 358–360. 34 indexed citations
18.
Manna, Laura, Fabrizio Vitale, Stefano Reale, et al.. (2008). Study of efficacy of miltefosine and allopurinol in dogs with leishmaniosis. The Veterinary Journal. 182(3). 441–445. 59 indexed citations
19.
Manna, Laura, Stefano Reale, Esther Picillo, Fabrizio Vitale, & Angelo Elio Gravino. (2008). Urine Sampling for Real-Time Polymerase Chain Reaction-Based Diagnosis of Canine Leishmaniasis. Journal of Veterinary Diagnostic Investigation. 20(1). 64–67. 25 indexed citations
20.
Manna, Laura, Stefano Reale, Fabrizio Vitale, et al.. (2007). Real-time PCR assay in Leishmania-infected dogs treated with meglumine antimoniate and allopurinol. The Veterinary Journal. 177(2). 279–282. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026